Decoy Therapeutics Inc. current report, 21 October 2019

全文

Business Context and Reporting Period

This Form 8-K is a current report filed by Salarius Pharmaceuticals, Inc. (not Decoy Therapeutics Inc.) on October 22, 2019, regarding events occurring on October 21, 2019. The filing documents the results of the Company's Annual Meeting of Stockholders. The registrant is an emerging growth company incorporated in Delaware.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and stockholder voting results.

Material Changes and Voting Results

Two proposals were submitted to stockholders and approved at the Annual Meeting:

  • Election of Directors: Stockholders elected William K. McVicar and Arnold C. Hanish to serve until the 2022 annual meeting.
    • William K. McVicar: 1,414,514 votes For; 2,235 votes Withheld; 1,081,393 Broker Non-Votes.
    • Arnold C. Hanish: 1,414,487 votes For; 2,262 votes Withheld; 1,081,393 Broker Non-Votes.
  • Ratification of Auditors: Stockholders ratified the appointment of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2019.
    • 2,483,578 votes For; 3,116 votes Against; 11,448 votes Abstain.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, contingencies, or unusual items. The document is limited to the procedural results of the stockholder vote.

Important Facts for Investors to Verify

  • Confirm the identity of the registrant as Salarius Pharmaceuticals, Inc. (Ticker: SLRX), noting the discrepancy with the requested company name (Decoy Therapeutics).
  • Verify the tenure of the newly elected directors (William K. McVicar and Arnold C. Hanish) extending to the 2022 annual meeting.
  • Confirm the appointment of Ernst & Young LLP as the independent auditor for the fiscal year ending December 31, 2019.
  • Note the significant number of broker non-votes (1,081,393) recorded for the director elections.